Pay in 4 interest-free payments of $7.03 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
it's metabolic freedom
The Wegovy pill is a prescription-only oral semaglutide treatment being developed to support weight management in adults living with obesity or weight-related health conditions
Individuals with: BMI of 30 or above BMI of 27 or above with a weight related condition Insulin resistance or prediabetes Obesity related metabolic risks However, formal prescribing guidelines will only be issued after licensing
Compare provider-reviewed options Research Snapshot Provider comparison Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages
Why are GLP-1 drugs so popular
Importantly, NICE guidance allows for empirical treatment to be started based on clinical suspicion, even before a definitive diagnosis is made
